Pallas Health vs Remedy Meds
Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.
24 of the 49 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.
Publishes both the intro price and the ongoing one in the same breath ($139 the first month, then $199) and is one of the few here that will sell you brand-name Mounjaro® alongside compounded options.
from $199/mo
Verified 2026-09-14
Compounded semaglutide and tirzepatide, with brand-name Ozempic or Zepbound on request, from a service that shows its prices ($189 every 28 days for the microdose plan, $299 for the standard dose) only after its sign-up quiz takes your name, email and phone. An FDA warning letter from September 2025 is still open and the BBB rates it F.
from $189 every 28 days for the microdose plan (standard dose: $299 every 28 days)
Verified 2026-10-27
Visit →Affiliate link
| Pallas Health | Remedy Meds | |
|---|---|---|
| Price | from $199/moTheir page, read 2026-09-14 | from $189 every 28 days for the microdose plan (standard dose: $299 every 28 days)Their page, read 2026-10-27 |
| Price shape | first-month-rises | one-ongoing-rate |
| What the price doesn’t say | $199/mo is the ongoing rate, and Pallas publishes it that way itself: its page reads “$139 first month · then $199/mo avg.” Tirzepatide is $179 first month then $299/mo. One fee covers provider care and shipping, with no separate membership charge. | $189 every 28 days is the microdose plan, a lower dose of compounded semaglutide or tirzepatide. The standard-dose plan is $299 every 28 days for semaglutide and $399 for tirzepatide. Billing every 28 days means 13 charges a year, and a paid period is not refunded. Prepaid bundles bring standard semaglutide down to $179 a month on a $2,148 year; Ozempic is $1,299 and Zepbound $1,399 every 28 days. These come from Remedy's sign-up quiz, read 27 October 2026, which shows plans only after the health questions and your name, email and phone, and which plans you are offered varies. Forbes Health listed $299, $399, $1,299 and $1,399 on 24 April 2026. |
| What it covers | Not published. The page does not say what the figure covers.Their page, read 2026-09-14 | Not published. The page does not say what the figure covers.Their page, read 2026-10-27 |
| Billed on top | Not recorded. We have not found a statement either way.Their page, read 2026-09-14 | In certain cases, you or your clinician associated with the Professional Entities may request that you complete services (e.g., medical consults or laboratory testing) not included in the Program Membership.Their page, read 2026-10-27 |
| Commitment | The page does not state whether a term is required. What happens after the first period: Publishes both figures in the same line: “Compounded Semaglutide — $139 first month · then $199/mo avg”, and the same for tirzepatide (“$179 first month · then $299/mo avg”).Their page, read 2026-09-14 | Cancel anytime. No term is required to get the published rate. What happens after the first period: Billed up front for the term you choose (every 28 days, or a 3, 6 or 12 month bundle) and renewed automatically until you cancel; the quiz's plan list has one price per plan and no separate first-payment price, so the renewal is the same as the first charge unless a campaign coupon applied. Its help center says the payment stays the same at every dose..Their page, read 2026-10-27 |
| Routes | compounded semaglutide, compounded tirzepatide, brand Mounjaro® | compounded semaglutide, compounded tirzepatide, GLP-1 microdosing, brand-name Ozempic, brand-name Zepbound |
| Score | 7.8 | 6.5 |
What is on the record
Documented findings, each with its source and date on the clinic’s review page. An FDA warning letter is an allegation by the agency, not a court ruling.
Pallas Health
Nothing documented in what we check.
Remedy Meds
- Regulatory actionFDA warning letter naming Remedy Meds
- The full record, with dates
What one does that the other doesn’t
Pallas Health
Nothing Remedy Meds does not also offer, on the routes we record.
Remedy Meds
Offers other, glp-1 (molecule unnamed) where Pallas Health does not.
Who each one suits
Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.
Pallas Health
- Scores clearly higher on transparency (8.5 vs 3.5).Basis: our published scoring rubric
- Scores clearly higher on pricing (7.0 vs 6.0).Basis: our published scoring rubric
Remedy Meds
- The two entry figures are not comparable: Pallas Health's rises after the first period.Basis: published price terms (introductory rate)
- Only one of the two offering: other, glp-1 (molecule unnamed).Basis: published treatments, by drug and route
Full write-ups: Pallas Health · Remedy Meds